Literature DB >> 27920610

Volumetric image-guided highly conformal radiotherapy of the prostate bed: Toxicity analysis.

Gianluca Ingrosso1, Alessandra Carosi1, Daniela di Cristino1, Elisabetta Ponti1, Andrea Lancia1, Alessandra Murgia1, Claudia Bruni1, Pasquale Morelli1, Franca Pietrasanta1, Riccardo Santoni1.   

Abstract

AIM: To evaluate toxicity of high conformal image-guided radiotherapy of the prostate bed.
BACKGROUND: Radiotherapy of the prostate bed has a pivotal role in the post-operative and salvage settings, but few clinical data are available on the use of daily image guidance in combination with highly conformal techniques, and data on long-term results are lacking.
MATERIALS AND METHODS: We analyzed 118 patients irradiated on the prostate bed using conformal plans processed with a micro-multileaf collimator, and daily checking treatment set-up with a cone-beam CT system. Correlation between toxicity and clinical-dosimetric parameters was assessed by the Cox regression model and log-rank test. Survival analyses were performed with the Kaplan-Meier method.
RESULTS: Median follow-up was 54.08 months. Late grade ≥2 gastro-intestinal (GI) and genito-urinary (GU) toxicity were 3.4% and 4.2%, respectively. Actuarial 4-year late grade ≥2 GI and GU toxicities were 4% and 6%, respectively. Four-year relapse-free survival was 87%. At log-rank test, acute grade ≥2 GI toxicity is associated with the use of antihypertensives (p = 0.03), and there is a trend toward significance between the use of anticoagulants and late grade ≥2 GI toxicity (p = 0.07). At Cox analysis, acute grade ≥2 GU toxicity is correlated with the percentage of bladder volume receiving more than 65 Gy (p = 0.02, HR 1.87 CI 1.25-2.8), and the maximal dose to the rectum is correlated to the development of late grade ≥2 GI toxicity (p = 0.03, HR 2.75 CI 1.10-6.9).
CONCLUSIONS: Conformal volumetric image-guided radiotherapy of the prostate bed leads to low toxicity rates.

Entities:  

Keywords:  Conformal radiotherapy; Image-guided radiotherapy; Prostate bed; Toxicity

Year:  2016        PMID: 27920610      PMCID: PMC5126144          DOI: 10.1016/j.rpor.2016.10.006

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  34 in total

Review 1.  Adjuvant radiotherapy following radical prostatectomy for prostate cancer.

Authors:  Tiffany Daly; Brigid E Hickey; Margot Lehman; Daniel P Francis; Adrienne M See
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.

Authors:  Thomas Wiegel; Detlef Bartkowiak; Dirk Bottke; Claudia Bronner; Ursula Steiner; Alessandra Siegmann; Reinhard Golz; Stephan Störkel; Normann Willich; Axel Semjonow; Michael Stöckle; Christian Rübe; Udo Rebmann; Tilman Kälble; Horst Jürgen Feldmann; Manfred Wirth; Rainer Hofmann; Rita Engenhart-Cabillic; Axel Hinke; Wolfgang Hinkelbein; Kurt Miller
Journal:  Eur Urol       Date:  2014-03-21       Impact factor: 20.096

3.  Magnetic resonance imaging in postprostatectomy radiotherapy planning.

Authors:  Jana Sefrova; Karel Odrazka; Petr Paluska; Zdenek Belobradek; Milos Brodak; Martin Dolezel; Petr Prosvic; Zuzana Macingova; Milan Vosmik; Petr Hoffmann; Miroslav Louda; Anna Nejedla
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-21       Impact factor: 7.038

4.  Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.

Authors:  Shawn Malone; Jennifer Croke; Nicolas Roustan-Delatour; Eric Belanger; Leonard Avruch; Colin Malone; Christopher Morash; Cathleen Kayser; Kathryn Underhill; Yan Li; Kyle Malone; Balazs Nyiri; Johanna Spaans
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-22       Impact factor: 7.038

5.  Postoperative radiotherapy in prostate cancer: Analysis of prognostic factors in a series of 282 patients.

Authors:  Giuseppina Apicella; Debora Beldì; Giansilvio Marchioro; Sara Torrente; Sara Tunesi; Corrado Magnani; Alessandro Volpe; Carlo Terrone; Marco Krengli
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-01

6.  Adaptive radiation therapy for postprostatectomy patients using real-time electromagnetic target motion tracking during external beam radiation therapy.

Authors:  Mingyao Zhu; Shyam Bharat; Jeff M Michalski; Hiram A Gay; Wei-Hsien Hou; Parag J Parikh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-25       Impact factor: 7.038

7.  Clinical correlations between treatment with anticoagulants/antiaggregants and late rectal toxicity after radiotherapy for prostate cancer.

Authors:  Ken Takeda; Yoshihiro Ogawa; Hisanori Ariga; Masashi Koto; Toru Sakayauchi; Keisuke Fujimoto; Kakutaro Narazaki; Masatoshi Mitsuya; Yoshihiro Takai; Shogo Yamada
Journal:  Anticancer Res       Date:  2009-05       Impact factor: 2.480

8.  Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer.

Authors:  Sameer K Nath; Ajay P Sandhu; Brent S Rose; Daniel R Simpson; Polly D Nobiensky; Jia-Zhu Wang; Fred Millard; Christopher J Kane; J Kellogg Parsons; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-24       Impact factor: 7.038

9.  Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.

Authors:  Gert De Meerleer; Valérie Fonteyne; Sabine Meersschout; Caroline Van den Broecke; Geert Villeirs; Nicolaas Lumen; Piet Ost; Katrien Vandecasteele; Wilfried De Neve
Journal:  Radiother Oncol       Date:  2008-09-02       Impact factor: 6.280

10.  Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.

Authors:  Gordon W Wong; Kerrin L Palazzi-Churas; David F Jarrard; David R Paolone; Andrew K Graf; Sean P Hedican; John D Wegenke; Mark A Ritter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-14       Impact factor: 7.038

View more
  3 in total

1.  Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer.

Authors:  Leif-Erik D Schumacher; Alan Dal Pra; Sarah E Hoffe; Eric A Mellon
Journal:  Br J Radiol       Date:  2020-08-12       Impact factor: 3.039

2.  Salvage radiation therapy in prostate cancer: relationship between rectal dose and long-term, self-reported rectal bleeding.

Authors:  K Braide; J Kindblom; U Lindencrona; J Hugosson; N Pettersson
Journal:  Clin Transl Oncol       Date:  2020-07-03       Impact factor: 3.405

3.  Tomotherapy-based moderate hypofractionation for localized prostate cancer: a mono-institutional analysis.

Authors:  Maria Valentina Tenti; Gianluca Ingrosso; Vittorio Bini; Cristina Mariucci; Simonetta Saldi; Emanuele Alì; Claudio Zucchetti; Rita Bellavita; Cynthia Aristei
Journal:  Rep Pract Oncol Radiother       Date:  2022-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.